Clinton hammers a whole sector by criticizing an increase in Epipens.
Shares of Gilead Sciences were lower Wednesday after Leerink cut its price target on the shares.
Shares of the world's second largest generic pharma company fell nearly 5% after U.S. politicians target company for price gouging.
Pfizer is making another acquisition.
The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.
Pescara Del Tronto was one of the hardest hit towns in Central Italy as an earthquake rattled the country overnight.
Senators Grassley, Blumenthal and Klobuchar demand Mylan reduce the price of its dominant treatment for life-threatening allergies.
Shares of the agrochemical giant got a boost Tuesday, following news Bayer AG may be courting the company with a sweeter deal.
Stocks hold onto gains through the morning session as new home sales hit a nearly eight-year high in July.
The FDA approved Merck's Keytruda, a drug to treat metastatic and recurrent cancer.